Winardi Wira, Wahyuni Hendra, Hidayat Moulid, Wirawan Aditya, Nurwidya Fariz, Uddin Mohammad N, Yusup Mohamad
Department of Pulmonology and Respiratory Medicine, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia.
Faculty of Medicine, Universitas Malikussaleh, Lhokseumawe, Indonesia.
Narra J. 2022 Aug;2(2):e80. doi: 10.52225/narra.v2i2.80. Epub 2022 Aug 1.
Indonesia is among the top three countries globally with the highest tuberculosis burden. During the past decades, Indonesian health authorities have struggled to improve tuberculosis care quality in health care facilities by optimizing the regulation and strengthening the private sector contributions. The coronavirus disease 2019 (COVID-19) pandemic has hardly affected the Indonesian health care system, including the National Tuberculosis Control Program. While the end of the COVID-19 pandemic in Indonesia is uncertain, the measure to control tuberculosis must not be weakened. Early identification and measurement of the problem size are essential to decide the most appropriate approach to maintain the sustainability of National Tuberculosis Control Program, particularly in health care facilities during the COVID-19 pandemic. This article points out the possible threats to the sustainability of TB care in Indonesia during the COVID-19 pandemic, including some approaches to overcome those problems.
印度尼西亚是全球结核病负担最高的三个国家之一。在过去几十年里，印度尼西亚卫生当局一直在努力通过优化监管和加强私营部门的贡献来提高医疗机构的结核病护理质量。2019年冠状病毒病（COVID-19）大流行几乎没有影响印度尼西亚的医疗系统，包括国家结核病控制项目。虽然印度尼西亚COVID-19大流行的结束时间尚不确定，但控制结核病的措施绝不能削弱。早期识别和衡量问题规模对于确定维持国家结核病控制项目可持续性的最合适方法至关重要，特别是在COVID-19大流行期间的医疗机构中。本文指出了COVID-19大流行期间印度尼西亚结核病护理可持续性可能面临的威胁，包括一些克服这些问题的方法。
